149 related articles for article (PubMed ID: 75788)
1. [Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid].
Fehér VJ; Jakab L; Tenczer J; Szilvási I
Dtsch Z Verdau Stoffwechselkr; 1977; 37(4):175-9. PubMed ID: 75788
[No Abstract] [Full Text] [Related]
2. [Current views on the liver-protective therapy: clinical evaluation of 4-amino-5-carbamide imidazole 2,4-dihydroxy-6-pyrimidine carbonate].
Tàmmaro AE; Bonaccorso O
Clin Ter; 1975 Oct; 75(2):141-51. PubMed ID: 1227763
[No Abstract] [Full Text] [Related]
3. [Clinical trials of Aicamin].
Azzena D; Trasciatti S; Capuzzo R
Minerva Dietol Gastroenterol; 1977; 23(4):345-51. PubMed ID: 349423
[No Abstract] [Full Text] [Related]
4. [Clinical experience report on Hepavis].
Menninger U; Menninger W
Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
[No Abstract] [Full Text] [Related]
5. [Controlled clinical evaluation of the therapeutic effectiveness of AICA orotate in chronic hepatitis].
Roda E; Sama C; Festi D
Clin Ter; 1979 Jun; 89(5):489-93. PubMed ID: 535326
[No Abstract] [Full Text] [Related]
6. [Clinical experimentation with Aïcamine in hepatic insufficiency].
Négret JP
Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
[No Abstract] [Full Text] [Related]
7. Hepatoprotective and immunological effects of antioxidant drugs.
Láng I; Nékám K; González-Cabello R; Mũzes G; Gergely P; Fehér J
Tokai J Exp Clin Med; 1990 May; 15(2-3):123-7. PubMed ID: 1983370
[TBL] [Abstract][Full Text] [Related]
8. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
Busin S; Micheli PL; Sovera A
Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
[No Abstract] [Full Text] [Related]
9. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
Busse K; Otremba P
Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
[No Abstract] [Full Text] [Related]
10. [Effect of oral solcoseryl administration on liver metabolism in patients with chronic liver diseases].
Reikowski J; Müting D
Wien Med Wochenschr; 1975 Dec; 125(49):716-9. PubMed ID: 820085
[No Abstract] [Full Text] [Related]
11. [Anabolic steroids and liver diseases].
Wewalka F
Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
[No Abstract] [Full Text] [Related]
12. Free radicals in tissue damage in liver diseases and therapeutic approach.
Fehér J; Láng I; Deák G; Cornides A; Nékám K; Gergely P
Tokai J Exp Clin Med; 1986; 11 Suppl():121-34. PubMed ID: 3452238
[TBL] [Abstract][Full Text] [Related]
13. [Physiopathological and clinical significance of the most important laboratory findings in hepatitis and cirrhosis].
Kommerell B; Stiehl A
Med Welt; 1970 Apr; 15():672-6. PubMed ID: 4108582
[No Abstract] [Full Text] [Related]
14. [Value of an orotic acid-sorbitol combination in hepato-intestinal diseases. Point of view of a general practitioner].
Lechat S; Pattin S; Vigne J
Rev Corps Sante Armees Terre Mer Air; 1967 Apr; 8(2):259-66. PubMed ID: 4237949
[No Abstract] [Full Text] [Related]
15. [Current problems in the treatment of hepatic cirrhosis].
Oancea R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(4):303-10. PubMed ID: 6173910
[No Abstract] [Full Text] [Related]
16. [Ureidosuccinate of 5(4)amino-4(5)imidazolecarboxamide: biopsy study after "controlled" use of the new substance in hepatic therapy].
Cavazzuti F
Clin Ter; 1977 Nov; 83(3):243-77. PubMed ID: 603982
[No Abstract] [Full Text] [Related]
17. [The effect of magnesium orotate and orotic acid on the enzyme activity of the liver. Experimental studies].
Szelényi I
Munch Med Wochenschr; 1970 Aug; 112(34):1516-9. PubMed ID: 4317840
[No Abstract] [Full Text] [Related]
18. [Epicritical evaluation of the submicroscopic aspects induced with administration of hepatotropic drugs].
Martines G; Cagnetta G; Rizzello M; Copponi V
Arch Sci Med (Torino); 1979; 136(3):337-56. PubMed ID: 549543
[TBL] [Abstract][Full Text] [Related]
19. [Pathophysiological study on lipoid metabolism in the liver under the influence of orotic acid and magnesium orotate].
Szelenyi I; Pucsõk J; Nemesãnsky E; Sós J
Arzneimittelforschung; 1971 Jun; 21(6):777-9. PubMed ID: 5109257
[No Abstract] [Full Text] [Related]
20. Reversibility of cirrhosis in autoimmune hepatitis.
Malekzadeh R; Mohamadnejad M; Nasseri-Moghaddam S; Rakhshani N; Tavangar SM; Sohrabpour AA; Tahaghoghi S
Am J Med; 2004 Jul; 117(2):125-9. PubMed ID: 15234650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
